Mirati Marks Another Milestone With Adagrasib

US FDA Grants Breakthrough Designation

Neon Light Sign Lungs Icon
Mirati received a breakthrough therapy designation from the FDA for KRAS G12C inhibitor adagrasib • Source: Shutterstock

More from Strategy

More from Business